$MDCC Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in MOLECULAR DEVICES CORP.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of all insider trading transactions in MOLECULAR DEVICES CORP. Get notifications about new insider transactions in MOLECULAR DEVICES CORP for free.
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Nov 05 2004 | MDCC | MOLECULAR DEVICES ... | Finkel Alan | CTO/Sr Vice Preside ... | Sell | S | 20.97 | 250 | 5,243 | 564,836 | 565.1 K to 564.8 K (-0.04 %) |
Nov 05 2004 | MDCC | MOLECULAR DEVICES ... | Finkel Alan | CTO/Sr Vice Preside ... | Sell | S | 20.98 | 1,100 | 23,078 | 565,086 | 566.2 K to 565.1 K (-0.19 %) |
Nov 05 2004 | MDCC | MOLECULAR DEVICES ... | Finkel Alan | CTO/Sr Vice Preside ... | Sell | S | 21.00 | 30 | 630 | 566,186 | 566.2 K to 566.2 K (-0.01 %) |
Nov 05 2004 | MDCC | MOLECULAR DEVICES ... | Finkel Alan | CTO/Sr Vice Preside ... | Sell | S | 21.25 | 125,000 | 2,656,250 | 478,637 | 603.6 K to 478.6 K (-20.71 %) |
Nov 05 2004 | MDCC | MOLECULAR DEVICES ... | Finkel Alan | CTO/Sr Vice Preside ... | Sell | S | 20.94 | 50 | 1,047 | 603,637 | 603.7 K to 603.6 K (-0.01 %) |
Nov 05 2004 | MDCC | MOLECULAR DEVICES ... | Finkel Alan | CTO/Sr Vice Preside ... | Sell | S | 20.95 | 23,469 | 491,676 | 603,687 | 627.2 K to 603.7 K (-3.74 %) |
Nov 05 2004 | MDCC | MOLECULAR DEVICES ... | Finkel Alan | CTO/Sr Vice Preside ... | Sell | S | 20.96 | 100 | 2,096 | 627,156 | 627.3 K to 627.2 K (-0.02 %) |
Nov 05 2004 | MDCC | MOLECULAR DEVICES ... | Finkel Alan | CTO/Sr Vice Preside ... | Sell | S | 20.97 | 250 | 5,243 | 627,256 | 627.5 K to 627.3 K (-0.04 %) |
Nov 05 2004 | MDCC | MOLECULAR DEVICES ... | Finkel Alan | CTO/Sr Vice Preside ... | Sell | S | 20.98 | 1,100 | 23,078 | 627,506 | 628.6 K to 627.5 K (-0.17 %) |
Nov 05 2004 | MDCC | MOLECULAR DEVICES ... | Finkel Alan | CTO/Sr Vice Preside ... | Sell | S | 21.00 | 31 | 651 | 628,606 | 628.6 K to 628.6 K (0.00 %) |
Nov 03 2004 | MDCC | MOLECULAR DEVICES ... | KEEGAN JOSEPH D | CEO/President | Buy | P | 18.99 | 8,152 | 154,806 | 14,234 | 6.1 K to 14.2 K (+134.03 %) |
Nov 03 2004 | MDCC | MOLECULAR DEVICES ... | KEEGAN JOSEPH D | CEO/President | Buy | J | 17.35 | 230 | 3,991 | 6,082 | 5.9 K to 6.1 K (+3.93 %) |
Sep 01 2004 | MDCC | MOLECULAR DEVICES ... | OLENIC THOMAS J | VP Sales and Servic ... | Option Exercise | M | 15.85 | 2,137 | 33,871 | 14,063 | |
Sep 01 2004 | MDCC | MOLECULAR DEVICES ... | OLENIC THOMAS J | VP Sales and Servic ... | Option Exercise | M | 20.20 | 17,736 | 358,267 | 22,264 | |
Sep 01 2004 | MDCC | MOLECULAR DEVICES ... | OLENIC THOMAS J | VP Sales and Servic ... | Option Exercise | M | 17.06 | 1,095 | 18,681 | 305 | |
Sep 01 2004 | MDCC | MOLECULAR DEVICES ... | OLENIC THOMAS J | VP Sales and Servic ... | Sell | S | 23.01 | 200 | 4,602 | 644 | 844 to 644 (-23.70 %) |
Sep 01 2004 | MDCC | MOLECULAR DEVICES ... | OLENIC THOMAS J | VP Sales and Servic ... | Sell | S | 23.00 | 9,136 | 210,128 | 844 | 10 K to 844 (-91.54 %) |
Sep 01 2004 | MDCC | MOLECULAR DEVICES ... | OLENIC THOMAS J | VP Sales and Servic ... | Sell | S | 23.02 | 100 | 2,302 | 9,980 | 10.1 K to 10 K (-0.99 %) |
Sep 01 2004 | MDCC | MOLECULAR DEVICES ... | OLENIC THOMAS J | VP Sales and Servic ... | Sell | S | 23.04 | 1,200 | 27,648 | 10,080 | 11.3 K to 10.1 K (-10.64 %) |
Sep 01 2004 | MDCC | MOLECULAR DEVICES ... | OLENIC THOMAS J | VP Sales and Servic ... | Sell | S | 23.05 | 600 | 13,830 | 11,280 | 11.9 K to 11.3 K (-5.05 %) |
Sep 01 2004 | MDCC | MOLECULAR DEVICES ... | OLENIC THOMAS J | VP Sales and Servic ... | Sell | S | 23.08 | 800 | 18,464 | 11,880 | 12.7 K to 11.9 K (-6.31 %) |
Sep 01 2004 | MDCC | MOLECULAR DEVICES ... | OLENIC THOMAS J | VP Sales and Servic ... | Sell | S | 23.07 | 5,700 | 131,499 | 12,680 | 18.4 K to 12.7 K (-31.01 %) |
Sep 01 2004 | MDCC | MOLECULAR DEVICES ... | OLENIC THOMAS J | VP Sales and Servic ... | Sell | S | 23.10 | 2,137 | 49,365 | 18,380 | 20.5 K to 18.4 K (-10.42 %) |
Sep 01 2004 | MDCC | MOLECULAR DEVICES ... | OLENIC THOMAS J | VP Sales and Servic ... | Sell | S | 23.10 | 1,095 | 25,295 | 20,517 | 21.6 K to 20.5 K (-5.07 %) |
Sep 01 2004 | MDCC | MOLECULAR DEVICES ... | OLENIC THOMAS J | VP Sales and Servic ... | Buy | M | 20.20 | 17,736 | 358,267 | 21,612 | 3.9 K to 21.6 K (+457.59 %) |
Sep 01 2004 | MDCC | MOLECULAR DEVICES ... | OLENIC THOMAS J | VP Sales and Servic ... | Buy | M | 15.85 | 2,137 | 33,871 | 3,876 | 1.7 K to 3.9 K (+122.89 %) |
Sep 01 2004 | MDCC | MOLECULAR DEVICES ... | OLENIC THOMAS J | VP Sales and Servic ... | Buy | M | 17.06 | 1,095 | 18,681 | 1,739 | 644 to 1.7 K (+170.03 %) |
Aug 30 2004 | MDCC | MOLECULAR DEVICES ... | OLENIC THOMAS J | VP Sales and Servic ... | Option Exercise | M | 15.85 | 6,300 | 99,855 | 16,200 | |
Aug 30 2004 | MDCC | MOLECULAR DEVICES ... | OLENIC THOMAS J | VP Sales and Servic ... | Option Exercise | M | 15.37 | 1,200 | 18,444 | 0 | |
Aug 30 2004 | MDCC | MOLECULAR DEVICES ... | OLENIC THOMAS J | VP Sales and Servic ... | Sell | S | 24.77 | 1,000 | 24,770 | 644 | 1.6 K to 644 (-60.83 %) |
Aug 30 2004 | MDCC | MOLECULAR DEVICES ... | OLENIC THOMAS J | VP Sales and Servic ... | Sell | S | 24.75 | 5,300 | 131,175 | 1,644 | 6.9 K to 1.6 K (-76.32 %) |
Aug 30 2004 | MDCC | MOLECULAR DEVICES ... | OLENIC THOMAS J | VP Sales and Servic ... | Buy | M | 15.85 | 6,300 | 99,855 | 6,944 | 644 to 6.9 K (+978.26 %) |
Aug 30 2004 | MDCC | MOLECULAR DEVICES ... | OLENIC THOMAS J | VP Sales and Servic ... | Sell | S | 24.75 | 1,200 | 29,700 | 644 | 1.8 K to 644 (-65.08 %) |
Aug 30 2004 | MDCC | MOLECULAR DEVICES ... | OLENIC THOMAS J | VP Sales and Servic ... | Buy | M | 15.37 | 1,200 | 18,444 | 1,844 | 644 to 1.8 K (+186.34 %) |
Aug 30 2004 | MDCC | MOLECULAR DEVICES ... | OLENIC THOMAS J | VP Sales and Servic ... | Buy | J | 17.35 | 58 | 1,006 | 644 | 586 to 644 (+9.90 %) |
Aug 27 2004 | MDCC | MOLECULAR DEVICES ... | BOWMAN A BLAINE | Director | Sell | S | 24.10 | 2,500 | 60,250 | 48,166 | 50.7 K to 48.2 K (-4.93 %) |
Aug 27 2004 | MDCC | MOLECULAR DEVICES ... | BOWMAN A BLAINE | Director | Sell | S | 24.09 | 3,000 | 72,270 | 50,666 | 53.7 K to 50.7 K (-5.59 %) |
Aug 27 2004 | MDCC | MOLECULAR DEVICES ... | BOWMAN A BLAINE | Director | Sell | S | 24.04 | 13,000 | 312,520 | 53,666 | 66.7 K to 53.7 K (-19.50 %) |
Aug 27 2004 | MDCC | MOLECULAR DEVICES ... | BOWMAN A BLAINE | Director | Sell | S | 24.00 | 8,000 | 192,000 | 66,666 | 74.7 K to 66.7 K (-10.71 %) |
Aug 27 2004 | MDCC | MOLECULAR DEVICES ... | BOWMAN A BLAINE | Director | Sell | S | 24.05 | 1,000 | 24,050 | 74,666 | 75.7 K to 74.7 K (-1.32 %) |
Aug 27 2004 | MDCC | MOLECULAR DEVICES ... | BOWMAN A BLAINE | Director | Sell | S | 24.07 | 12,500 | 300,875 | 75,666 | 88.2 K to 75.7 K (-14.18 %) |
Aug 25 2004 | MDCC | MOLECULAR DEVICES ... | HUMPHRIES GILLIAN M K | VP Strategic Affair ... | Option Exercise | M | 15.37 | 6,000 | 92,220 | 0 | |
Aug 25 2004 | MDCC | MOLECULAR DEVICES ... | HUMPHRIES GILLIAN M K | VP Strategic Affair ... | Sell | S | 23.81 | 2,800 | 66,668 | 0 | 2.8 K to 0 (-100.00 %) |
Aug 25 2004 | MDCC | MOLECULAR DEVICES ... | HUMPHRIES GILLIAN M K | VP Strategic Affair ... | Sell | S | 23.82 | 200 | 4,764 | 2,800 | 3 K to 2.8 K (-6.67 %) |
Aug 25 2004 | MDCC | MOLECULAR DEVICES ... | HUMPHRIES GILLIAN M K | VP Strategic Affair ... | Sell | S | 23.90 | 1,600 | 38,240 | 3,000 | 4.6 K to 3 K (-34.78 %) |
Aug 25 2004 | MDCC | MOLECULAR DEVICES ... | HUMPHRIES GILLIAN M K | VP Strategic Affair ... | Sell | S | 23.91 | 100 | 2,391 | 4,600 | 4.7 K to 4.6 K (-2.13 %) |
Aug 25 2004 | MDCC | MOLECULAR DEVICES ... | HUMPHRIES GILLIAN M K | VP Strategic Affair ... | Sell | S | 23.92 | 200 | 4,784 | 4,700 | 4.9 K to 4.7 K (-4.08 %) |
Aug 25 2004 | MDCC | MOLECULAR DEVICES ... | HUMPHRIES GILLIAN M K | VP Strategic Affair ... | Sell | S | 23.93 | 1,100 | 26,323 | 4,900 | 6 K to 4.9 K (-18.33 %) |
Aug 25 2004 | MDCC | MOLECULAR DEVICES ... | HUMPHRIES GILLIAN M K | VP Strategic Affair ... | Grant | A | 15.37 | 6,000 | 92,220 | 6,000 | 0 to 6 K |
Aug 11 2004 | MDCC | MOLECULAR DEVICES ... | Finkel Alan | CTO/Sr Vice Preside ... | Sell | S | 20.36 | 150,000 | 3,054,000 | 566,216 | 716.2 K to 566.2 K (-20.94 %) |
Aug 11 2004 | MDCC | MOLECULAR DEVICES ... | Finkel Alan | CTO/Sr Vice Preside ... | Sell | S | 20.36 | 150,000 | 3,054,000 | 628,637 | 778.6 K to 628.6 K (-19.26 %) |
Aug 09 2004 | MDCC | MOLECULAR DEVICES ... | KEEGAN JOSEPH D | CEO/President | Buy | P | 20.94 | 300 | 6,282 | 5,852 | 5.6 K to 5.9 K (+5.40 %) |
Aug 09 2004 | MDCC | MOLECULAR DEVICES ... | KEEGAN JOSEPH D | CEO/President | Buy | P | 20.93 | 2,900 | 60,697 | 5,552 | 2.7 K to 5.6 K (+109.35 %) |
Aug 09 2004 | MDCC | MOLECULAR DEVICES ... | KEEGAN JOSEPH D | CEO/President | Buy | P | 20.92 | 1,600 | 33,472 | 2,652 | 1.1 K to 2.7 K (+152.09 %) |
Aug 09 2004 | MDCC | MOLECULAR DEVICES ... | KEEGAN JOSEPH D | CEO/President | Buy | P | 20.91 | 200 | 4,182 | 1,052 | 852 to 1.1 K (+23.47 %) |
Aug 03 2004 | MDCC | MOLECULAR DEVICES ... | Finkel Alan | CTO/Sr Vice Preside ... | Option Exercise | M | 1.56 | 11,743 | 18,319 | 0 | |
Aug 03 2004 | MDCC | MOLECULAR DEVICES ... | Finkel Alan | CTO/Sr Vice Preside ... | Option Exercise | M | 9.52 | 15,658 | 149,064 | 0 | |
Aug 03 2004 | MDCC | MOLECULAR DEVICES ... | Finkel Alan | CTO/Sr Vice Preside ... | Sell | S | 20.15 | 25,628 | 516,404 | 778,637 | 804.3 K to 778.6 K (-3.19 %) |
Aug 03 2004 | MDCC | MOLECULAR DEVICES ... | Finkel Alan | CTO/Sr Vice Preside ... | Sell | S | 20.16 | 1,300 | 26,208 | 804,265 | 805.6 K to 804.3 K (-0.16 %) |
Aug 03 2004 | MDCC | MOLECULAR DEVICES ... | Finkel Alan | CTO/Sr Vice Preside ... | Sell | S | 20.17 | 400 | 8,068 | 805,565 | 806 K to 805.6 K (-0.05 %) |
Aug 03 2004 | MDCC | MOLECULAR DEVICES ... | Finkel Alan | CTO/Sr Vice Preside ... | Sell | S | 20.20 | 73 | 1,475 | 805,965 | 806 K to 806 K (-0.01 %) |
Aug 03 2004 | MDCC | MOLECULAR DEVICES ... | Finkel Alan | CTO/Sr Vice Preside ... | Buy | M | 1.56 | 11,743 | 18,319 | 806,038 | 794.3 K to 806 K (+1.48 %) |
Aug 03 2004 | MDCC | MOLECULAR DEVICES ... | Finkel Alan | CTO/Sr Vice Preside ... | Buy | M | 9.52 | 15,658 | 149,064 | 794,295 | 778.6 K to 794.3 K (+2.01 %) |
Jul 06 2004 | MDCC | MOLECULAR DEVICES ... | Finkel Alan | CTO/Sr Vice Preside ... | Option Exercise | A | 0.00 | 29 | 0 | 1,653 | |
Jul 06 2004 | MDCC | MOLECULAR DEVICES ... | Finkel Alan | CTO/Sr Vice Preside ... | Option Exercise | A | 0.00 | 29 | 0 | 1,624 | |
Jul 06 2004 | MDCC | MOLECULAR DEVICES ... | Finkel Alan | CTO/Sr Vice Preside ... | Option Exercise | A | 0.00 | 1,595 | 0 | 1,595 | |
Jul 06 2004 | MDCC | MOLECULAR DEVICES ... | Finkel Alan | CTO/Sr Vice Preside ... | Option Exercise | A | 0.00 | 983 | 0 | 983 | |
Jul 06 2004 | MDCC | MOLECULAR DEVICES ... | Finkel Alan | CTO/Sr Vice Preside ... | Option Exercise | A | 0.00 | 29 | 0 | 865 | |
Jul 06 2004 | MDCC | MOLECULAR DEVICES ... | Finkel Alan | CTO/Sr Vice Preside ... | Option Exercise | A | 0.00 | 836 | 0 | 836 | |
Jul 06 2004 | MDCC | MOLECULAR DEVICES ... | Finkel Alan | CTO/Sr Vice Preside ... | Option Exercise | A | 46.32 | 483 | 22,373 | 483 | |
Jul 06 2004 | MDCC | MOLECULAR DEVICES ... | Finkel Alan | CTO/Sr Vice Preside ... | Option Exercise | A | 1.56 | 11,743 | 18,319 | 11,743 | |
Jul 06 2004 | MDCC | MOLECULAR DEVICES ... | Finkel Alan | CTO/Sr Vice Preside ... | Option Exercise | A | 46.32 | 5,388 | 249,572 | 5,388 | |
Jul 06 2004 | MDCC | MOLECULAR DEVICES ... | Finkel Alan | CTO/Sr Vice Preside ... | Option Exercise | A | 9.52 | 15,658 | 149,064 | 15,658 | |
Jul 06 2004 | MDCC | MOLECULAR DEVICES ... | Finkel Alan | CTO/Sr Vice Preside ... | Grant | A | 0.00 | 73 | 0 | 715,777 | 715.7 K to 715.8 K (+0.01 %) |
Jul 06 2004 | MDCC | MOLECULAR DEVICES ... | Finkel Alan | CTO/Sr Vice Preside ... | Grant | A | 0.00 | 73 | 0 | 715,704 | 715.6 K to 715.7 K (+0.01 %) |
Jul 06 2004 | MDCC | MOLECULAR DEVICES ... | Finkel Alan | CTO/Sr Vice Preside ... | Grant | A | 0.00 | 715,631 | 0 | 715,631 | 0 to 715.6 K |
Jul 06 2004 | MDCC | MOLECULAR DEVICES ... | Finkel Alan | CTO/Sr Vice Preside ... | Grant | A | 0.00 | 778,264 | 0 | 778,264 | 0 to 778.3 K |
Jul 02 2004 | MDCC | MOLECULAR DEVICES ... | WAITZ J ALLAN | Director | Option Exercise | A | 17.94 | 4,000 | 71,760 | 4,000 | |
Jul 02 2004 | MDCC | MOLECULAR DEVICES ... | MCCONNELL HARDEN M | Director | Option Exercise | A | 17.94 | 4,000 | 71,760 | 4,000 | |
Jul 02 2004 | MDCC | MOLECULAR DEVICES ... | MARION ANDRE F | Director | Option Exercise | A | 17.94 | 4,000 | 71,760 | 4,000 | |
Jul 02 2004 | MDCC | MOLECULAR DEVICES ... | GODDARD PAUL | Director | Option Exercise | A | 17.94 | 4,000 | 71,760 | 4,000 | |
Jul 02 2004 | MDCC | MOLECULAR DEVICES ... | BOWMAN A BLAINE | Director | Option Exercise | A | 17.94 | 4,000 | 71,760 | 4,000 | |
Jul 02 2004 | MDCC | MOLECULAR DEVICES ... | ANDERSON DAVID L | Director | Option Exercise | A | 17.94 | 4,000 | 71,760 | 4,000 | |
Jul 02 2004 | MDCC | MOLECULAR DEVICES ... | ALAFI MOSHE | Director | Option Exercise | A | 17.94 | 4,000 | 71,760 | 4,000 | |
Feb 12 2004 | MDCC | MOLECULAR DEVICES ... | ZANDER ANDREW T | VP Engineering | Option Exercise | A | 19.66 | 25,000 | 491,500 | 25,000 | |
Feb 12 2004 | MDCC | MOLECULAR DEVICES ... | ZANDER ANDREW T | VP Engineering | Buy | J | 14.32 | 445 | 6,372 | 3,130 | 2.7 K to 3.1 K (+16.57 %) |
Feb 12 2004 | MDCC | MOLECULAR DEVICES ... | ZANDER ANDREW T | VP Engineering | Buy | J | 14.32 | 442 | 6,329 | 2,685 | 2.2 K to 2.7 K (+19.71 %) |
Feb 12 2004 | MDCC | MOLECULAR DEVICES ... | SPORTSMAN J RICHARD | VP Assay & Reagent | Option Exercise | A | 19.66 | 25,000 | 491,500 | 25,000 | |
Feb 12 2004 | MDCC | MOLECULAR DEVICES ... | SPORTSMAN J RICHARD | VP Assay & Reagent | Buy | J | 14.32 | 307 | 4,396 | 1,390 | 1.1 K to 1.4 K (+28.35 %) |
Feb 12 2004 | MDCC | MOLECULAR DEVICES ... | SPORTSMAN J RICHARD | VP Assay & Reagent | Buy | J | 14.32 | 305 | 4,368 | 1,083 | 778 to 1.1 K (+39.20 %) |
Feb 12 2004 | MDCC | MOLECULAR DEVICES ... | SHARP PATRICIA | VP Human Resource | Option Exercise | A | 19.66 | 25,000 | 491,500 | 25,000 | |
Feb 12 2004 | MDCC | MOLECULAR DEVICES ... | SHARP PATRICIA | VP Human Resource | Buy | J | 14.32 | 211 | 3,022 | 3,325 | 3.1 K to 3.3 K (+6.78 %) |
Feb 12 2004 | MDCC | MOLECULAR DEVICES ... | OLENIC THOMAS J | VP Sales and Servic ... | Option Exercise | A | 19.66 | 25,000 | 491,500 | 25,000 | |
Feb 12 2004 | MDCC | MOLECULAR DEVICES ... | OLENIC THOMAS J | VP Sales and Servic ... | Buy | J | 14.32 | 68 | 974 | 586 | 518 to 586 (+13.13 %) |
Feb 12 2004 | MDCC | MOLECULAR DEVICES ... | OLENIC THOMAS J | VP Sales and Servic ... | Buy | J | 14.32 | 68 | 974 | 518 | 450 to 518 (+15.11 %) |
Feb 12 2004 | MDCC | MOLECULAR DEVICES ... | OLDFIELD STEPHEN J | VP Marketing | Option Exercise | A | 19.66 | 25,000 | 491,500 | 25,000 | |
Feb 12 2004 | MDCC | MOLECULAR DEVICES ... | MURRAY ROBERT JOSEPH | VP Operations | Option Exercise | A | 19.66 | 25,000 | 491,500 | 25,000 | |
Feb 12 2004 | MDCC | MOLECULAR DEVICES ... | MURRAY ROBERT JOSEPH | VP Operations | Buy | J | 14.32 | 391 | 5,599 | 27,998 | 27.6 K to 28 K (+1.42 %) |
Feb 12 2004 | MDCC | MOLECULAR DEVICES ... | MURRAY ROBERT JOSEPH | VP Operations | Buy | J | 14.32 | 704 | 10,081 | 27,607 | 26.9 K to 27.6 K (+2.62 %) |
Feb 12 2004 | MDCC | MOLECULAR DEVICES ... | MCCONNELL HARDEN M | Director | Sell | S | 19.32 | 100 | 1,932 | 249,000 | 249.1 K to 249 K (-0.04 %) |
Feb 12 2004 | MDCC | MOLECULAR DEVICES ... | MCCONNELL HARDEN M | Director | Sell | S | 19.37 | 677 | 13,113 | 249,100 | 249.8 K to 249.1 K (-0.27 %) |
Feb 12 2004 | MDCC | MOLECULAR DEVICES ... | MCCONNELL HARDEN M | Director | Sell | S | 19.31 | 101 | 1,950 | 249,777 | 249.9 K to 249.8 K (-0.04 %) |
Feb 12 2004 | MDCC | MOLECULAR DEVICES ... | MCCONNELL HARDEN M | Director | Sell | S | 19.20 | 400 | 7,680 | 249,878 | 250.3 K to 249.9 K (-0.16 %) |
Feb 12 2004 | MDCC | MOLECULAR DEVICES ... | MCCONNELL HARDEN M | Director | Sell | S | 19.20 | 469 | 9,005 | 250,278 | 250.7 K to 250.3 K (-0.19 %) |
Feb 12 2004 | MDCC | MOLECULAR DEVICES ... | MCCONNELL HARDEN M | Director | Sell | S | 19.19 | 200 | 3,838 | 250,747 | 250.9 K to 250.7 K (-0.08 %) |
Feb 12 2004 | MDCC | MOLECULAR DEVICES ... | MCCONNELL HARDEN M | Director | Sell | S | 19.15 | 53 | 1,015 | 250,947 | 251 K to 250.9 K (-0.02 %) |
Feb 12 2004 | MDCC | MOLECULAR DEVICES ... | MCCONNELL HARDEN M | Director | Gift | G | 0.00 | 3,600 | 0 | 251,000 | 254.6 K to 251 K (-1.41 %) |
Feb 12 2004 | MDCC | MOLECULAR DEVICES ... | MCCONNELL HARDEN M | Director | Gift | G | 0.00 | 1,200 | 0 | 254,600 | 253.4 K to 254.6 K (+0.47 %) |
Feb 12 2004 | MDCC | MOLECULAR DEVICES ... | MCCONNELL HARDEN M | Director | Gift | G | 0.00 | 1,200 | 0 | 253,400 | 252.2 K to 253.4 K (+0.48 %) |
Feb 12 2004 | MDCC | MOLECULAR DEVICES ... | MCCONNELL HARDEN M | Director | Gift | G | 0.00 | 1,200 | 0 | 252,200 | 251 K to 252.2 K (+0.48 %) |
Feb 12 2004 | MDCC | MOLECULAR DEVICES ... | KEEGAN JOSEPH D | CEO/President | Option Exercise | A | 19.66 | 60,000 | 1,179,600 | 60,000 | |
Feb 12 2004 | MDCC | MOLECULAR DEVICES ... | KEEGAN JOSEPH D | CEO/President | Buy | J | 14.32 | 273 | 3,909 | 852 | 579 to 852 (+47.15 %) |
Feb 12 2004 | MDCC | MOLECULAR DEVICES ... | KEEGAN JOSEPH D | CEO/President | Buy | J | 14.32 | 272 | 3,895 | 579 | 307 to 579 (+88.60 %) |
Feb 12 2004 | MDCC | MOLECULAR DEVICES ... | HARKNESS TIMOTHY | CEO/VP Finance | Option Exercise | A | 19.66 | 35,000 | 688,100 | 35,000 | |
Feb 12 2004 | MDCC | MOLECULAR DEVICES ... | HARKNESS TIMOTHY | CEO/VP Finance | Buy | J | 14.32 | 420 | 6,014 | 5,721 | 5.3 K to 5.7 K (+7.92 %) |
Feb 12 2004 | MDCC | MOLECULAR DEVICES ... | HARKNESS TIMOTHY | CEO/VP Finance | Buy | J | 14.32 | 414 | 5,928 | 5,301 | 4.9 K to 5.3 K (+8.47 %) |
Feb 12 2004 | MDCC | MOLECULAR DEVICES ... | HUMPHRIES GILLIAN M K | VP Strategic Affair ... | Option Exercise | A | 19.66 | 10,000 | 196,600 | 10,000 |